ALPHATEC HOLDINGS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
ALPHATEC HOLDINGS, INC. (ATEC) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $18.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $18.15M, a 16.15% increase year-over-year.
- ALPHATEC HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $23.66M, a 6.01% increase year-over-year.
- ALPHATEC HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $16.38M, a 6.20% decline year-over-year.
- ALPHATEC HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $15.62M, a 7.88% decline year-over-year.
- ALPHATEC HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $73.72M, a 0.60% increase from fiscal 2024.
- ALPHATEC HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $73.28M, a 9.81% decline from fiscal 2023.
- ALPHATEC HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $81.24M, a 116.13% increase from fiscal 2022.
- ALPHATEC HOLDINGS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $37.59M, a 8.24% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.15M 10-Q · filed 2026-08-04 | $41.81M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $23.66M 10-Q · filed 2026-08-04 | |||
| 2025-12-31 | $73.72M 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $16.38M 10-Q · filed 2025-10-30 | $32.00M derived: sum of 2 quarters · filed 2026-08-04 | $54.32M derived: sum of 3 quarters · filed 2026-08-04 | |
| 2025-06-30 | $15.62M 10-Q · filed 2026-08-04 | $37.94M derived: sum of 2 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $22.32M 10-Q · filed 2026-08-04 | |||
| 2024-12-31 | $73.28M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $17.46M 10-Q · filed 2025-10-30 | $34.42M derived: sum of 2 quarters · filed 2025-10-30 | $51.74M derived: sum of 3 quarters · filed 2025-10-30 | |
| 2024-06-30 | $16.96M 10-Q · filed 2025-10-30 | $34.28M derived: sum of 2 quarters · filed 2025-10-30 | ||
| 2024-03-31 | $17.32M 10-Q · filed 2025-10-30 | |||
| 2023-12-31 | $81.24M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $20.07M 10-Q · filed 2024-10-30 | $44.27M derived: sum of 2 quarters · filed 2024-10-30 | $60.73M derived: sum of 3 quarters · filed 2024-10-30 | |
| 2023-06-30 | $24.19M 10-Q · filed 2024-10-30 | $40.66M derived: sum of 2 quarters · filed 2024-10-30 | ||
| 2023-03-31 | $16.46M 10-Q · filed 2024-10-30 | |||
| 2022-12-31 | $37.59M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $10.01M 10-Q · filed 2023-11-06 | $20.12M derived: sum of 2 quarters · filed 2023-11-06 | $27.85M derived: sum of 3 quarters · filed 2023-11-06 | |
| 2022-06-30 | $10.11M 10-Q · filed 2023-11-06 | $17.84M derived: sum of 2 quarters · filed 2023-11-06 | ||
| 2022-03-31 | $7.73M 10-Q · filed 2023-11-06 | |||
| 2021-12-31 | $34.73M 10-K · filed 2024-02-27 | |||
| 2021-09-30 | $10.30M 10-Q · filed 2022-11-03 | $21.49M derived: sum of 2 quarters · filed 2022-11-03 | $25.38M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $11.19M 10-Q · filed 2022-11-03 | $15.08M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $3.89M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $15.73M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $4.76M 10-Q · filed 2021-11-04 | $8.37M derived: sum of 2 quarters · filed 2021-11-04 | $12.00M derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | $3.61M 10-Q · filed 2021-11-04 | $7.24M derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $3.63M 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $10.29M 10-K · filed 2021-03-05 | |||
| 2019-09-30 | $3.41M 10-Q · filed 2020-11-05 | $5.55M derived: sum of 2 quarters · filed 2020-11-05 | $7.12M derived: sum of 3 quarters · filed 2020-11-05 | |
| 2019-06-30 | $2.14M 10-Q · filed 2020-11-05 | $3.71M derived: sum of 2 quarters · filed 2020-11-05 | ||
| 2019-03-31 | $1.56M 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $5.65M 10-K · filed 2020-03-17 | |||
| 2018-09-30 | $1.72M 10-Q · filed 2019-11-01 | $2.94M derived: sum of 2 quarters · filed 2019-11-01 | $3.75M derived: sum of 3 quarters · filed 2019-11-01 | |
| 2018-06-30 | $1.22M 10-Q · filed 2019-11-01 | $2.03M derived: sum of 2 quarters · filed 2019-11-01 | ||
| 2018-03-31 | $812.00K 10-Q · filed 2019-11-01 | |||
| 2017-12-31 | $3.90M 10-K · filed 2019-03-29 | |||
| 2016-12-31 | $1.63M 10-K · filed 2018-03-09 | |||
| 2015-12-31 | $2.56M 10-K · filed 2017-03-31 | |||
| 2014-12-31 | $2.69M 10-K · filed 2017-03-31 | |||
| 2013-12-31 | $2.59M 10-K · filed 2016-03-15 | |||
| 2012-12-31 | $2.41M 10-K · filed 2015-02-27 | |||
| 2011-12-31 | $2.52M 10-K · filed 2014-03-20 | |||
| 2010-12-31 | $3.33M 10-K · filed 2013-03-05 | |||
| 2009-12-31 | $3.22M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |